ZAI LAB LIMITED Operating Income
ZAI LAB LIMITED (ZLAB) reported Operating Income of -$76.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- ZAI LAB LIMITED operating income (loss) for the quarter ending 2026-06-30 was -$76.49M.
- ZAI LAB LIMITED operating income (loss) for the quarter ending 2026-03-31 was -$69.39M.
- ZAI LAB LIMITED operating income (loss) for the quarter ending 2025-12-31 was -$69.41M.
- ZAI LAB LIMITED operating income (loss) for the quarter ending 2025-09-30 was -$48.82M.
- ZAI LAB LIMITED operating income (loss) for fiscal 2025 was -$229.43M.
- ZAI LAB LIMITED operating income (loss) for fiscal 2024 was -$282.12M.
- ZAI LAB LIMITED operating income (loss) for fiscal 2023 was -$366.57M.
- ZAI LAB LIMITED operating income (loss) for fiscal 2022 was -$404.36M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$76.49M 10-Q · filed 2026-08-06 | -$145.87M 10-Q · filed 2026-08-06 | -$215.28M derived: sum of 3 quarters · filed 2026-08-06 | -$264.10M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$69.39M 10-Q · filed 2026-05-07 | -$138.79M derived: sum of 2 quarters · filed 2026-05-07 | -$187.61M derived: sum of 3 quarters · filed 2026-05-07 | -$242.51M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$69.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$118.23M derived: sum of 2 quarters · filed 2026-02-26 | -$173.12M derived: sum of 3 quarters · filed 2026-08-06 | -$229.43M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$48.82M 10-Q · filed 2025-11-06 | -$103.72M derived: sum of 2 quarters · filed 2026-08-06 | -$160.03M 10-Q · filed 2025-11-06 | -$227.92M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$54.90M 10-Q · filed 2026-08-06 | -$111.21M 10-Q · filed 2026-08-06 | -$179.10M derived: sum of 3 quarters · filed 2026-08-06 | -$246.95M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$56.31M 10-Q · filed 2026-05-07 | -$124.20M derived: sum of 2 quarters · filed 2026-05-07 | -$192.06M derived: sum of 3 quarters · filed 2026-05-07 | -$268.12M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$67.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$135.74M derived: sum of 2 quarters · filed 2026-02-26 | -$211.81M derived: sum of 3 quarters · filed 2026-02-26 | -$282.12M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$67.85M 10-Q · filed 2025-11-06 | -$143.92M derived: sum of 2 quarters · filed 2025-11-06 | -$214.23M 10-Q · filed 2025-11-06 | -$338.21M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$76.06M 10-Q · filed 2025-08-07 | -$146.37M 10-Q · filed 2025-08-07 | -$270.35M derived: sum of 3 quarters · filed 2026-02-26 | -$353.92M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$70.31M 10-Q · filed 2025-05-08 | -$194.29M derived: sum of 2 quarters · filed 2026-02-26 | -$277.86M derived: sum of 3 quarters · filed 2026-02-26 | -$367.36M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$123.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$207.55M derived: sum of 2 quarters · filed 2026-02-26 | -$297.05M derived: sum of 3 quarters · filed 2026-02-26 | -$366.57M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$83.57M 10-Q · filed 2024-11-12 | -$173.07M derived: sum of 2 quarters · filed 2024-11-12 | -$242.59M 10-Q · filed 2024-11-12 | -$339.89M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | -$89.50M 10-Q · filed 2024-08-06 | -$159.02M 10-Q · filed 2024-08-06 | -$256.32M derived: sum of 3 quarters · filed 2025-02-27 | -$384.90M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | -$69.52M 10-Q · filed 2024-05-08 | -$166.81M derived: sum of 2 quarters · filed 2025-02-27 | -$295.40M derived: sum of 3 quarters · filed 2025-02-27 | -$394.11M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | -$97.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$225.88M derived: sum of 2 quarters · filed 2025-02-27 | -$324.59M derived: sum of 3 quarters · filed 2025-02-27 | -$404.36M 10-K · filed 2025-02-27 | |
| 2022-09-30 | -$128.58M 10-Q · filed 2023-11-07 | -$227.30M derived: sum of 2 quarters · filed 2023-11-07 | -$307.06M 10-Q · filed 2023-11-07 | -$526.26M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$98.72M 10-Q · filed 2023-08-07 | -$178.48M 10-Q · filed 2023-08-07 | -$397.68M derived: sum of 3 quarters · filed 2023-08-07 | -$480.88M derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | -$79.76M 10-Q · filed 2023-05-09 | -$298.96M derived: sum of 2 quarters · filed 2023-05-09 | -$382.17M derived: sum of 3 quarters · filed 2023-05-09 | -$552.74M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | -$219.20M 10-K · filed 2022-03-01 | -$302.40M derived: sum of 2 quarters · filed 2022-11-09 | -$472.97M derived: sum of 3 quarters · filed 2022-11-09 | -$700.06M 10-K · filed 2024-02-27 | |
| 2021-09-30 | -$83.20M 10-Q · filed 2022-11-09 | -$253.78M derived: sum of 2 quarters · filed 2022-11-09 | -$480.87M 10-Q · filed 2022-11-09 | -$576.12M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | -$170.57M 10-Q · filed 2022-08-09 | -$397.66M 10-Q · filed 2022-08-09 | -$492.92M derived: sum of 3 quarters · filed 2022-08-09 | -$569.18M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | -$227.09M 10-Q · filed 2022-05-10 | -$322.35M derived: sum of 2 quarters · filed 2022-05-10 | -$398.61M derived: sum of 3 quarters · filed 2022-05-10 | -$482.57M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$95.26M 10-K · filed 2022-03-01 | -$171.51M derived: sum of 2 quarters · filed 2022-03-01 | -$255.48M derived: sum of 3 quarters · filed 2022-03-01 | -$301.80M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$76.26M 10-K · filed 2022-03-01 | -$160.22M derived: sum of 2 quarters · filed 2022-03-01 | -$206.54M 10-Q · filed 2021-11-09 | -$258.59M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | -$83.97M 10-K · filed 2022-03-01 | -$130.29M 10-Q · filed 2021-08-09 | -$182.34M derived: sum of 3 quarters · filed 2022-03-01 | -$247.60M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$46.32M 10-K · filed 2022-03-01 | -$98.37M derived: sum of 2 quarters · filed 2022-03-01 | -$163.64M derived: sum of 3 quarters · filed 2022-03-01 | ||
| 2019-12-31 | -$52.05M derived: 10-K 12 month − 6-K 9 month · filed 2022-03-01 | -$117.32M derived: sum of 2 quarters · filed 2022-03-01 | -$203.20M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$65.27M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$151.15M 6-K · filed 2020-01-21 | |||
| 2019-06-30 | -$85.88M 6-K · filed 2020-09-11 | ||||
| 2018-12-31 | -$66.54M derived: 10-K 12 month − 6-K 9 month · filed 2021-03-01 | -$141.77M 10-K · filed 2021-03-01 | -$141.77M 20-F · filed 2019-03-29 | ||
| 2018-09-30 | -$75.22M 6-K · filed 2020-01-21 | ||||
| 2017-12-31 | -$51.39M 20-F · filed 2020-04-29 | -$51.39M 20-F · filed 2018-04-30 | |||
| 2016-12-31 | -$38.53M 20-F · filed 2019-03-29 | ||||
| 2015-12-31 | -$16.35M 20-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |